Emerald Health Therapeutics, Inc.
Emerald Health Therapeutics, Inc. (EMHTF) Revenue
Annual & quarterly revenue history · segment & region breakdown
EMHTF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsEmerald Health Therapeutics, Inc. trailing twelve-month (TTM) revenue is $0.01B, a decrease of 17.56% year-over-year from $0.01B in FY2021.
Revenue trend
2021 – 2009 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2021-12-31 | $0.01B | -$0.00B | -17.56% |
| 2020-12-31 | $0.01B | -$0.01B | -42.22% |
| 2019-12-31 | $0.02B | +$0.02B | +943.07% |
| 2018-12-31 | $0.00B | +$0.00B | +107.75% |
| 2017-12-31 | $0.00B | +$0.00B | +270.14% |
| 2016-12-31 | $0.00B | +$0.00B | +709.57% |
| 2015-12-31 | $0.00B | +$0.00B | — |
| 2014-12-31 | $0.00B | -$0.00B | -100.00% |
| 2013-03-31 | $0.00B | -$0.00B | -49.71% |
| 2012-03-31 | $0.00B | +$0.00B | +401.89% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Emerald Health Therapeutics, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Emerald Health Therapeutics, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in CAD.
Data sourced from Emerald Health Therapeutics, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
EMHTF revenue · 4 questionsEMHTF's trailing twelve-month (TTM) revenue is $0.01B. That is a decrease of 17.56% year-over-year from $0.01B in FY2021.
▸ Source: FMP · Emerald Health Therapeutics, Inc. SEC filings · GAAP · Emerald Health Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026